世界のターゲットDNAシーケンス市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP03534)
◆英語タイトル:Global Targeted DNA Sequencing Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP03534
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月18日(※2024年版があります。お問い合わせください。)
◆ページ数:104
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、ターゲットDNAシーケンスの世界市場を広く調査・分析し、今後の市場展望をまとめております。ターゲットDNAシーケンスの種類別市場規模(エクソームシーケンス、エンリッチメントシーケンス、アンプリコンシーケンス、その他)、用途別市場規模(学術研究、病院、クリニック、製薬、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Illumina, Inc.、Thermo Fisher Scientific, Inc.、PierianDx、Roche、Oxford Nanopore Technologies、Agilent Technologies、BGI、GATC Biotech、Genomatix GmbH、QIAGEN、PerkinElmer, Inc.
・地域別グローバル市場分析 2015年-2020年
・ターゲットDNAシーケンスの北米市場(アメリカ、カナダ、メキシコ)
・ターゲットDNAシーケンスのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ターゲットDNAシーケンスのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ターゲットDNAシーケンスの南米市場(ブラジル、アルゼンチン)
・ターゲットDNAシーケンスの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:エクソームシーケンス、エンリッチメントシーケンス、アンプリコンシーケンス、その他
・用途別分析:学術研究、病院、クリニック、製薬、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The Targeted DNA Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Targeted DNA Sequencing sales will be xx in 2020 from Targeted DNA Sequencing million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Targeted DNA Sequencing market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Targeted DNA Sequencing industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Targeted DNA Sequencing and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Targeted DNA Sequencing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Targeted DNA Sequencing market has been segmented into:
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Others

By Application, Targeted DNA Sequencing has been segmented into:
Academic Research
Hospitals and Clinics
Pharma
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Targeted DNA Sequencing market presented in the report. This section sheds light on the sales growth of different regional and country-level Targeted DNA Sequencing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Targeted DNA Sequencing market.

The report offers in-depth assessment of the growth and other aspects of the Targeted DNA Sequencing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Targeted DNA Sequencing Market Share Analysis
Targeted DNA Sequencing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Targeted DNA Sequencing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Targeted DNA Sequencing sales, revenue and market share for each player covered in this report.

The major players covered in Targeted DNA Sequencing are:
Illumina, Inc.
Thermo Fisher Scientific, Inc.
PierianDx
Roche
Oxford Nanopore Technologies
Agilent Technologies
BGI
GATC Biotech
Genomatix GmbH
QIAGEN
PerkinElmer, Inc.
Among other players domestic and global, Targeted DNA Sequencing market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Targeted DNA Sequencing Market Overview
1.1 Product Overview and Scope of Targeted DNA Sequencing
1.2 Classification of Targeted DNA Sequencing by Type
1.2.1 Global Targeted DNA Sequencing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Targeted DNA Sequencing Revenue Market Share by Type in 2019
1.2.3 Exome Sequencing
1.2.4 Enrichment Sequencing
1.2.5 Amplicon Sequencing
1.2.6 Others
1.3 Global Targeted DNA Sequencing Market by Application
1.3.1 Overview: Global Targeted DNA Sequencing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Academic Research
1.3.3 Hospitals and Clinics
1.3.4 Pharma
1.3.5 Other
1.4 Global Targeted DNA Sequencing Market by Regions
1.4.1 Global Targeted DNA Sequencing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Targeted DNA Sequencing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Targeted DNA Sequencing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Targeted DNA Sequencing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Targeted DNA Sequencing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Targeted DNA Sequencing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Targeted DNA Sequencing Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Targeted DNA Sequencing Industry Impact
1.5.1 COVID-19 Potential Implications for the Targeted DNA Sequencing
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Targeted DNA Sequencing
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Illumina, Inc.
2.1.1 Illumina, Inc. Details
2.1.2 Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Illumina, Inc. SWOT Analysis
2.1.4 Illumina, Inc. Product and Services
2.1.5 Illumina, Inc. Targeted DNA Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Thermo Fisher Scientific, Inc.
2.2.1 Thermo Fisher Scientific, Inc. Details
2.2.2 Thermo Fisher Scientific, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Thermo Fisher Scientific, Inc. SWOT Analysis
2.2.4 Thermo Fisher Scientific, Inc. Product and Services
2.2.5 Thermo Fisher Scientific, Inc. Targeted DNA Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.3 PierianDx
2.3.1 PierianDx Details
2.3.2 PierianDx Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 PierianDx SWOT Analysis
2.3.4 PierianDx Product and Services
2.3.5 PierianDx Targeted DNA Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Targeted DNA Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Oxford Nanopore Technologies
2.5.1 Oxford Nanopore Technologies Details
2.5.2 Oxford Nanopore Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Oxford Nanopore Technologies SWOT Analysis
2.5.4 Oxford Nanopore Technologies Product and Services
2.5.5 Oxford Nanopore Technologies Targeted DNA Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Agilent Technologies
2.6.1 Agilent Technologies Details
2.6.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Agilent Technologies SWOT Analysis
2.6.4 Agilent Technologies Product and Services
2.6.5 Agilent Technologies Targeted DNA Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.7 BGI
2.7.1 BGI Details
2.7.2 BGI Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 BGI SWOT Analysis
2.7.4 BGI Product and Services
2.7.5 BGI Targeted DNA Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.8 GATC Biotech
2.8.1 GATC Biotech Details
2.8.2 GATC Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GATC Biotech SWOT Analysis
2.8.4 GATC Biotech Product and Services
2.8.5 GATC Biotech Targeted DNA Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Genomatix GmbH
2.9.1 Genomatix GmbH Details
2.9.2 Genomatix GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Genomatix GmbH SWOT Analysis
2.9.4 Genomatix GmbH Product and Services
2.9.5 Genomatix GmbH Targeted DNA Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.10 QIAGEN
2.10.1 QIAGEN Details
2.10.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 QIAGEN SWOT Analysis
2.10.4 QIAGEN Product and Services
2.10.5 QIAGEN Targeted DNA Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.11 PerkinElmer, Inc.
2.11.1 PerkinElmer, Inc. Details
2.11.2 PerkinElmer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 PerkinElmer, Inc. SWOT Analysis
2.11.4 PerkinElmer, Inc. Product and Services
2.11.5 PerkinElmer, Inc. Targeted DNA Sequencing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Targeted DNA Sequencing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Targeted DNA Sequencing Players Market Share
3.2.2 Top 10 Targeted DNA Sequencing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Targeted DNA Sequencing Revenue and Market Share by Regions
4.2 North America Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
4.3 Europe Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
4.5 South America Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
5 North America Targeted DNA Sequencing Revenue by Countries
5.1 North America Targeted DNA Sequencing Revenue by Countries (2015-2020)
5.2 USA Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
5.3 Canada Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
5.4 Mexico Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
6 Europe Targeted DNA Sequencing Revenue by Countries
6.1 Europe Targeted DNA Sequencing Revenue by Countries (2015-2020)
6.2 Germany Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
6.3 UK Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
6.4 France Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
6.5 Russia Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
6.6 Italy Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Targeted DNA Sequencing Revenue by Countries
7.1 Asia-Pacific Targeted DNA Sequencing Revenue by Countries (2015-2020)
7.2 China Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
7.3 Japan Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
7.4 Korea Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
7.5 India Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
8 South America Targeted DNA Sequencing Revenue by Countries
8.1 South America Targeted DNA Sequencing Revenue by Countries (2015-2020)
8.2 Brazil Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
8.3 Argentina Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Targeted DNA Sequencing by Countries
9.1 Middle East & Africa Targeted DNA Sequencing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
9.3 UAE Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
9.4 Egypt Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
9.5 South Africa Targeted DNA Sequencing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Targeted DNA Sequencing Revenue and Market Share by Type (2015-2020)
10.2 Global Targeted DNA Sequencing Market Forecast by Type (2019-2024)
10.3 Exome Sequencing Revenue Growth Rate (2015-2025)
10.4 Enrichment Sequencing Revenue Growth Rate (2015-2025)
10.5 Amplicon Sequencing Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Targeted DNA Sequencing Market Segment by Application
11.1 Global Targeted DNA Sequencing Revenue Market Share by Application (2015-2020)
11.2 Targeted DNA Sequencing Market Forecast by Application (2019-2024)
11.3 Academic Research Revenue Growth (2015-2020)
11.4 Hospitals and Clinics Revenue Growth (2015-2020)
11.5 Pharma Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Targeted DNA Sequencing Market Size Forecast (2021-2025)
12.1 Global Targeted DNA Sequencing Market Size Forecast (2021-2025)
12.2 Global Targeted DNA Sequencing Market Forecast by Regions (2021-2025)
12.3 North America Targeted DNA Sequencing Revenue Market Forecast (2021-2025)
12.4 Europe Targeted DNA Sequencing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Targeted DNA Sequencing Revenue Market Forecast (2021-2025)
12.6 South America Targeted DNA Sequencing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Targeted DNA Sequencing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Illumina, Inc.、Thermo Fisher Scientific, Inc.、PierianDx、Roche、Oxford Nanopore Technologies、Agilent Technologies、BGI、GATC Biotech、Genomatix GmbH、QIAGEN、PerkinElmer, Inc.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のターゲットDNAシーケンス市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Targeted DNA Sequencing Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。